Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 20,000 shares at $119.47 ($2.4M) on 2022-01-14, disclosed to the SEC on 2022-01-14.
Seasonal sale ($2.4M) by CVP, Critical Care — this insider has traded EW in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.47 | 8,884 | $1.1M | 44.4% |
| 2 | $119.47 | 8,884 | $1.1M | 44.4% |
| 3 | $120.01 | 1,116 | $134K | 5.6% |
| 4 | $120.01 | 1,116 | $134K | 5.6% |
| Total | $119.53 avg | 20,000 | $2.4M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |